X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21562) 21562
Book Review (3977) 3977
Publication (1415) 1415
Book Chapter (179) 179
Conference Proceeding (49) 49
Dissertation (22) 22
Government Document (13) 13
Newsletter (8) 8
Magazine Article (6) 6
Newspaper Article (3) 3
Journal / eJournal (2) 2
Paper (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Data Set (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
radical prostatectomy (17331) 17331
index medicus (15853) 15853
humans (15085) 15085
male (14394) 14394
prostate cancer (11628) 11628
urology & nephrology (9649) 9649
aged (7934) 7934
middle aged (7929) 7929
prostatic neoplasms - pathology (6059) 6059
oncology (5769) 5769
cancer (5623) 5623
prostatic neoplasms - surgery (4926) 4926
prostatectomy (4195) 4195
surgery (3479) 3479
prostate-specific antigen - blood (3262) 3262
men (3123) 3123
treatment outcome (2967) 2967
urology (2934) 2934
radiotherapy (2850) 2850
prognosis (2817) 2817
carcinoma (2760) 2760
care and treatment (2645) 2645
neoplasm staging (2471) 2471
aged, 80 and over (2448) 2448
retrospective studies (2445) 2445
prostate (2444) 2444
adult (2342) 2342
prostatic neoplasms - therapy (2332) 2332
prostatectomy - methods (2276) 2276
prostatic neoplasms - diagnosis (2266) 2266
abridged index medicus (2265) 2265
risk factors (2173) 2173
prostatic neoplasms - radiotherapy (2136) 2136
biopsy (2123) 2123
prostatic neoplasms - blood (2082) 2082
outcomes (2032) 2032
radiation-therapy (1960) 1960
research (1940) 1940
radiology, nuclear medicine & medical imaging (1885) 1885
analysis (1861) 1861
diagnosis (1843) 1843
survival (1790) 1790
risk (1772) 1772
prostatic neoplasms - mortality (1753) 1753
antigen (1704) 1704
health aspects (1689) 1689
prostate-specific antigen (1672) 1672
follow-up studies (1647) 1647
radical retropubic prostatectomy (1525) 1525
prostate - pathology (1522) 1522
quality-of-life (1499) 1499
adenocarcinoma (1478) 1478
mortality (1446) 1446
prostatic neoplasms (1444) 1444
recurrence (1408) 1408
prostatectomy - adverse effects (1364) 1364
progression (1358) 1358
quality of life (1349) 1349
therapy (1319) 1319
prospective studies (1283) 1283
medicine & public health (1274) 1274
time factors (1272) 1272
biochemical recurrence (1255) 1255
laparoscopy (1239) 1239
female (1179) 1179
disease-free survival (1166) 1166
neoplasm grading (1108) 1108
metastasis (1085) 1085
predictive value of tests (1078) 1078
follow-up (1070) 1070
brachytherapy (1028) 1028
management (1014) 1014
active surveillance (986) 986
prostatic neoplasms - drug therapy (983) 983
gleason score (969) 969
disease progression (961) 961
experience (961) 961
pathology (961) 961
erectile dysfunction (944) 944
risk assessment (918) 918
impact (912) 912
article (904) 904
patient outcomes (887) 887
oncology, experimental (883) 883
multivariate analysis (866) 866
usage (853) 853
complications (825) 825
tumors (823) 823
patients (813) 813
prostatic neoplasms - genetics (813) 813
retropubic prostatectomy (813) 813
prostatic neoplasms - metabolism (811) 811
magnetic resonance imaging (804) 804
sensitivity and specificity (799) 799
medicine, general & internal (795) 795
radiation therapy (790) 790
robotics (789) 789
robotic surgery (782) 782
survival rate (776) 776
prostatic neoplasms - epidemiology (770) 770
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19575) 19575
French (746) 746
German (697) 697
Spanish (470) 470
Russian (117) 117
Japanese (63) 63
Turkish (34) 34
Hungarian (18) 18
Italian (18) 18
Portuguese (15) 15
Dutch (14) 14
Korean (11) 11
Chinese (7) 7
Polish (7) 7
Czech (6) 6
Lithuanian (3) 3
Swedish (3) 3
Slovak (2) 2
Croatian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Laparoscopic radical prostatectomy, 12/2005
Millions of men are diagnosed annually with prostate cancer worldwide. With the advent of PSA screening, there has been a shift in the detection of early... 
prostate cancer, laparoscopic prostatectomy, radical
Journal
BJU International, ISSN 1464-4096, 08/2016, Volume 118, Issue 2, pp. 302 - 306
Journal Article
BJU International, ISSN 1464-4096, 08/2015, Volume 116, Issue 2, pp. 230 - 235
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 5, pp. 846 - 853
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2169 - 2176
Purpose: Prostate cancer is dependent on androgen receptor (AR) activation. Optimal AR antagonism may effectively cytoreduce local disease and suppress or... 
THERAPY | ANTIANDROGEN | ONCOLOGY | RESISTANCE | PHASE-II | RADICAL PROSTATECTOMY | INCREASED SURVIVAL | CANCER | CHEMOTHERAPY | PROGRESSION | ABIRATERONE | Neoplasm, Residual - pathology | Phenylthiohydantoin - adverse effects | Prostatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Combined Modality Therapy | Neoplasm, Residual - blood | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Phenylthiohydantoin - administration & dosage | Receptors, Androgen - genetics | Leuprolide - administration & dosage | Neoadjuvant Therapy - adverse effects | Prostatic Neoplasms - blood | Prostatectomy | Aged | Neoplasm, Residual - chemically induced | Dutasteride - administration & dosage | Prostatic Neoplasms - drug therapy | Therapy | Risk groups | Health risks | Minimal residual disease | Patients | Anticancer properties | Testosterone | Signaling | Dihydrotestosterone | Androgens | Flutamide | Experimental design | Luteinizing hormone | Luteinizing hormone-releasing hormone | Antitumor activity | Prostate cancer | Prostate | Cancer | Index Medicus | dutasteride | neoadjuvant | NEW MOLECULAR TARGETS | THERAPEUTICS: Cellular responses to anticancer drugs | CL01 PHASE I – III CLINICAL TRIALS: Phase I–III Trials_Genitourinary cancers: prostate | ET02 MECHANISMS OF DRUG ACTION | enzalutamide
Journal Article
The Journal of Urology, ISSN 0022-5347, 2003, Volume 169, Issue 6, pp. 2289 - 2292
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2012, Volume 39, Issue 2, pp. 271 - 282
Journal Article
Journal Article